News + Filings Transactions
|
Rolph Timothy
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 509 | $55.16 | $28.1k | | 06/13/2023 |
| 03/10/2023 | Akero Therapeutics, Inc. | AKRO | Payment of Exercise | Common Stock | 603 | $43.47 | $26.2k | | 03/10/2023 |
| 12/29/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 7.8k | $28.35 | $221.6k | | 12/28/2022 |
| 12/29/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 12.3k | $51.38 | $631.6k | | 12/28/2022 |
| 12/29/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 8k | $50.55 | $405.5k | | 12/28/2022 |
| 12/28/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 1.7k | $50.00 | $85k | | 12/28/2022 |
| 12/28/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 1.7k | $28.35 | $48.2k | | 12/28/2022 |
| 12/16/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.4k | | 12/16/2022 |
| 12/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 19.2k | $0.00 | $0 | | 12/09/2022 |
| 12/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 86.4k | $42.95 | $3.7M | | 12/09/2022 |
| 11/16/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 100 | $46.05 | $4.6k | | 11/15/2022 |
| 11/16/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.8k | $45.45 | $174.9k | | 11/15/2022 |
| 11/15/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 3.1k | $45.04 | $141.3k | | 11/15/2022 |
| 10/06/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 22.5k | $39.29 | $884k | | 10/06/2022 |
| 10/06/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 10k | $21.09 | $210.9k | | 10/06/2022 |
| 09/30/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 22.5k | $31.38 | $706k | | 09/30/2022 |
| 09/30/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 22.5k | $34.06 | $766.4k | | 09/30/2022 |
| 09/30/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 6.3k | $6.36 | $40.2k | | 09/30/2022 |
| 09/30/2022 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 13.7k | $21.09 | $288.3k | | 09/30/2022 |
| 09/13/2022 | Akero Therapeutics, Inc. | AKRO | Sale | Common Stock | 22.5k | $29.18 | $656.6k | | 09/13/2022 |
| 09/13/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.5k | | 09/09/2022 |
| 09/09/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 29.1k | $21.10 | $613.5k | | 09/09/2022 |
| 06/30/2022 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 1.2k | $8.03 | $9.3k | | 09/09/2022 |
| 12/08/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 87.2k | $21.10 | $1.8M | | 12/08/2021 |
| 06/30/2021 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 1k | $21.09 | $21.2k | | 09/09/2022 |
| 12/08/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 77.6k | $28.35 | $2.2M | | 12/08/2020 |
| 06/30/2020 | Akero Therapeutics, Inc. | AKRO | Grant | Common Stock | 1.2k | $17.07 | $21.2k | | 12/08/2020 |
| 03/12/2020 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 27.4k | $0.61 | $16.7k | | 03/12/2020 |
| 03/12/2020 | Akero Therapeutics, Inc. | AKRO | Exercise | Stock Option (Right to Buy) | 22.7k | $0.61 | $13.8k | | 03/12/2020 |
| 12/13/2019 | Akero Therapeutics, Inc. | AKRO | Grant | Stock Option (Right to Buy) | 85k | $21.09 | $1.8M | | 12/13/2019 |
|